Latest Posts

Targeting Th17 cells the answer to Hidradenitis Suppurativa?

In a recent study from a research team led by Ussher Assistant Professor in Translational Immunology Jean Fletcher, researcher Barry Moran at Trinity College Dublin, and dermatologists Professor Brian Kirby at St. Vincent’s University Hospital, and Dr Anne-Marie Tobin at…
Read more

Hidradenitis Suppurativa In The Press

Nice to see that Hidradenitis Suppurativa has been getting a bit of press lately, hopefully this helps raise awareness! http://www.netdoctor.co.uk/beauty/skincare/a28319/hidradenitis-suppurativa-need-to-know/ http://www.dailymail.co.uk/health/article-4598982/Woman-MARBLE-sized-lumps-groin-thought-STI.html http://www.express.co.uk/life-style/health/813753/hidradenitis-suppurativa-symptoms-skin-disease https://www.therecord.com/news-story/7372112-painful-skin-condition-often-misdiagnosed/

Adalimumab results in high clinical response rates for HS

In a recent study, researchers found that the groups receiving adalimumab (40 mg weekly) had significantly greater improvement than the placebo groups at week 12. In period 1, patients were randomly assigned in a 1:1 ratio to 40 mg of…
Read more

Adalimumab (Humira) approved by NICE for NHS use

Adalimumab (Humira) has been approved by NICE for NHS use in the UK for people with active moderate to severe Hidradentitis. This comes after the medicine was approved for use in the EU in 2015. The NHS will pay a…
Read more

FDA approves Humira for Hidradenitis Suppurativa

The US Food and Drug Administration (FDA) has approved Humira for use on moderate to severe Hidradenitis Suppurativa. Humira is the first approved treatment for Hidradenitis Suppurativa. The approval comes after the EU approved Humira in July 2015 for use…
Read more

EU approves Humira for Hidradenitis Suppurativa

AbbVie’s Humira has gained an EU licence to be used for treating patients with moderate to severe Hidradenitis Suppurativa. The approval is based on the results of two 36-week, two-period pivotal Phase III studies in 633 people with moderate to severe HS. This is…
Read more

Humira (Adalimumab) for Hidradenitis Suppurativa gets positive opinion in Europe

Biopharmaceutical firm AbbVie’s Humira (adalimumab) has received positive opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) to treat adults with moderate to severe hidradenitis suppurativa. This positive opinion is based on the results…
Read more

No Cure

Remember there is no cure. Don’t be fooled into buying a so called cure! Although there is no current cure for Hidradenitis Suppurativa there are treatments to help manage the condition.

Updates

We have added a few pages to the site. About Hidradenitis Suppurativa is a page with frequently asked questions along with common treatments HS Research lists all the latest research into HS Clinical Trials lists all the latest open clinical trials….
Read more